Monoclonal Antibody Prevents Malaria in U.S. Adults, NIH Trial Shows
August 05, 2022
August 05, 2022
WASHINGTON, Aug. 5 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
* * *
Larger trials enrolling infants and children are underway in Mali and Kenya.
* * *
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a National Institutes . . .
* * *
Larger trials enrolling infants and children are underway in Mali and Kenya.
* * *
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a National Institutes . . .